About Proof Diagnostics
Proof Diagnostics is a Healthcare company based in Cambridge (United States) founded in 2020 by Omar Abudayyeh, Feng Zhang, and Jonathan Gootenberg, and was acquired by Ginkgo Bioworks in February 2024. CRISPR-based COVID-19 molecular testing devices are manufactured. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Viral. Its competitors include Curative, Aptitude Medical and Pearsanta; 1 of its 3 listed competitors has raised funding.
Company details
Proof Diagnostics, founded in 2020 in Cambridge, United States, focuses on life sciences, infectious diseases, in vitro diagnostic tests, viral, and sars-cov-2. Manufacturer of CRISPR based Covid-19 molecular testing device. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
- Headquarters Cambridge, United States
- Founders Omar Abudayyeh, Feng Zhang, Jonathan Gootenberg
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website proofdx.com
- Social LinkedIn X
- Acquired by Ginkgo Bioworks (Feb 2024)
- Investors
- Acquired byGinkgo Bioworks
(Feb 2024)
Investors in Proof Diagnostics
Proof Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Ginkgo Bioworks.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Gene editing-based cultured ingredients are provided for agriculture. | 2008 | ginkgobioworks.com | Boston, United States |
Investor details for Proof Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Proof Diagnostics
12 people are tracked at Proof Diagnostics (8 in leadership, 4 in board & advisors).
| Name | Role | Group |
|---|---|---|
Omar Abudayyeh | Co-Founder | Leadership |
Feng Zhang | Co-Founder | Leadership |
Jonathan Gootenberg | Co-Founder | Leadership |
Hedia Maamar | Chief Scientific Officer | Leadership |
Ragu Vijaykumar | Head of Digital Health & Systems Integration | Leadership |
Andy Golden | Director of Process Development | Leadership |
Ralph Hanna | VP, Operations | Leadership |
Aman Gill | Associate Director, Computational Biology | Leadership |
David Margulies | Advisor | Board & advisors |
Deborah T. Hung | Advisor | Board & advisors |
Stephen Knight | Director | Board & advisors |
Matt McIlwain | Director | Board & advisors |
Complete people profiles for Proof Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Proof Diagnostics
2 dated milestones of Proof Diagnostics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Proof Diagnostics is founded.
- Exit Acquired by Ginkgo Bioworks.
Competitors of Proof Diagnostics
Proof Diagnostics has 3 listed competitors in our database, 1 of them funded. They include Curative, Aptitude Medical and Pearsanta.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| curative.com | 2020 | Austin, United States | $9.8M | 2,251 | Curative is recognized for providing affordable employer-sponsored health insurance. | |
| aptitudemedical.com | 2011 | Goleta, United States | 44 | Provider of at-home COVID and COVID/Flu tests | ||
| pearsanta.com | 2023 | Richmond, United States | Offers personalized medical diagnostics and monitoring through data-driven technology. |
Detailed competitors of Proof Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Proof Diagnostics (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Proof Diagnostics
Complete news archive for Proof Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Proof Diagnostics
Proof Diagnostics was founded in 2020.
Proof Diagnostics is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Proof Diagnostics, founded in 2020 in Cambridge, United States, focuses on life sciences, infectious diseases, in vitro diagnostic tests, viral, and sars-cov-2. Manufacturer of CRISPR based Covid-19 molecular testing device. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.
Proof Diagnostics's top competitors include Curative, Aptitude Medical and Pearsanta.
Proof Diagnostics has 1 investor. Key investors include Ginkgo Bioworks.
Yes. Proof Diagnostics was acquired by Ginkgo Bioworks in February 2024.